¼¼°èÀÇ Drug Discovery ºÐ¾ß ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå º¸°í¼­(2025³â)
Lab Automation In Drug Discovery Global Market Report 2025
»óǰÄÚµå : 1691997
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,496,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,390,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,284,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Drug Discovery ºÐ¾ß ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̸ç 2029³â±îÁö 5.4%ÀÇ CAGR·Î 84¾ï ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº Á¦¾à»çÀÇ ÀǾàǰ ÆÄÀÌÇÁ¶óÀÎ È®´ë, ¸ÂÃãÇü ÀÇ·á ¹× Á¤¹Ð Ä¡·á¹ýÀÇ ºÎ»ó, Èñ±Í Áúȯ ¹× Èñ±Í ÀǾàǰ¿¡ ´ëÇÑ °ü½É Áõ°¡, ¿ø°Ý ¹× ºÐ»êÇü ÀÓ»ó½ÃÇè¿¡ ´ëÇÑ ¼ö¿ä, ¹Ì¼¼À¯Ã¼ ±â¼ú ¹× ·¦¿ÂĨ ±â¼úÀÇ ÃâÇö µî¿¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î ºÐ¼®µË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ¸ðµâ½Ä ¹× ¸ÂÃãÇü ÀÚµ¿È­ ¼Ö·ç¼ÇÀÇ È®»ê, µ¥ÀÌÅÍ °ü¸® ¹× Çù¾÷À» À§ÇÑ Å¬¶ó¿ìµå ±â¹Ý Ç÷§ÆûÀÇ Ã¤ÅÃ, ½ÅÈï±¹ ½ÃÀå¿¡¼­ÀÇ ÀÚµ¿È­ ¼ºÀå, ÀÚµ¿È­ ¹× µðÁöÅÐ ±â¼úÀ» Ȱ¿ëÇÑ °¡»ó ½Å¾à°³¹ß ±â¾÷ÀÇ ºÎ»ó, Ç¥ÁØÈ­µÈ ÇÁ·ÎÅäÄÝ ¹× »óÈ£ ÀÛ¿ëÇÏ´Â ÇÁ·ÎÅäÄÝÀÇ µîÀå, ¹Ì¼¼À¯Ã¼ ±â¼ú ¹× ·¦¿ÂĨ ±â¼úÀÇ ÃâÇöÀÌ ²ÅÇû½À´Ï´Ù. Ç¥ÁØÈ­µÈ ÇÁ·ÎÅäÄݰú »óÈ£ ¿î¿ë °¡´ÉÇÑ ½Ã½ºÅÛ °³¹ß µîÀ» ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù.

Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ½Å¾à°³¹ß ½ÃÀå¿¡¼­ ½ÇÇè½Ç ÀÚµ¿È­ÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¤¹ÐÀÇ·á´Â °³Àκ° À¯ÀüÀÚ, ȯ°æ, ¶óÀÌÇÁ½ºÅ¸ÀÏÀÇ °³ÀÎÂ÷¿¡ µû¶ó Ä¡·á ¹× ¿¹¹æ Àü·«À» Á¶Á¤ÇÏ´Â ¸ÂÃãÇü ÀÇ·á¶ó°íµµ ÇÕ´Ï´Ù. ½ÇÇè½Ç ÀÚµ¿È­´Â ¿¬±¸ °¡¼ÓÈ­, ½ÇÇè ÀçÇö¼º Çâ»ó, Á¤¹Ð ÀÇ·á ¹× ½Å¾à °³¹ß ÀýÂ÷ÀÇ È¿À²¼º Çâ»ó¿¡ ÀÖ¾î ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â °á±¹ ȯÀÚ °³°³Àο¡ ¸Â´Â º¸´Ù È¿°úÀûÀÎ ÀǾàǰ°ú Áø´Ü¹ý °³¹ß·Î À̾îÁý´Ï´Ù. °³ÀθÂÃãÀǷῬÇÕ(PMC)¿¡ µû¸£¸é, 2022³â 10¿ù¿¡´Â 75,000°³ ÀÌ»óÀÇ À¯ÀüÀÚ °Ë»ç Á¦Ç°°ú 300°³ ÀÌ»óÀÇ ¸ÂÃãÇü ÀǾàǰÀÌ ½ÃÀå¿¡ Ãâ½ÃµÇ¾î ´Ù¾çÇÑ À¯ÇüÀÇ ¾Ï, À¯ÀüÀû Èñ±ÍÁúȯ, ´Ù¾çÇÑ ¸¸¼ºÁúȯ ¹× °¨¿°¼º Áúȯ¿¡ ´ëÀÀÇÒ ¼ö ÀÖÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ½Å¾à°³¹ß ½ÃÀå¿¡¼­ ½ÇÇè½Ç ÀÚµ¿È­ÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.

½Å¾à°³¹ß ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀåÀÇ ¼±µµÀûÀÎ ±â¾÷µéÀº Àü·«ÀûÀ¸·Î ÷´Ü ¼Ö·ç¼Ç, ƯÈ÷ ½Å¼ÓÇÑ ¾ÆÀ̵ð¾î-µ¥ÀÌÅÍ Àüȯ ¼Ö·ç¼Ç °³¹ß¿¡ ÁýÁßÇÏ¿© °æÀï·ÂÀ» È®º¸Çϰí ÀÖ½À´Ï´Ù. ·¡ÇÇµå ¾ÆÀ̵ð¾î-µ¥ÀÌÅÍ ¼Ö·ç¼ÇÀº °³Àΰú Á¶Á÷ÀÌ ¾ÆÀ̵ð¾î¿Í °³³äÀ» ½ÇÇà °¡´ÉÇÑ ÀλçÀÌÆ®¿Í µ¥ÀÌÅÍ ±â¹Ý °á°ú·Î ºü¸£°Ô ÀüȯÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÏ´Â °£¼ÒÈ­µÈ ÇÁ·Î¼¼½º ¹× Ç÷§ÆûÀ» ¸»ÇÕ´Ï´Ù. Strateos Inc.´Â ÀúºÐÀÚ È­ÇÕ¹° Ž»öÀ» À§ÇÑ Rapid Idea-to-Data ¼Ö·ç¼ÇÀ» ÀÚ»çÀÇ Å¬¶ó¿ìµå ·¦ ÀÚµ¿È­ ¼­ºñ½º Ç÷§Æû¿¡ µµÀÔÇß½À´Ï´Ù. Á¦¾à °³¹ß¿¡¼­ ÀúºÐÀÚ È­ÇÕ¹° Ž»öÀ» À§ÇØ Æ¯º°È÷ ¼³°èµÈ ÀÌ ½ÇÇè½Ç ÀÚµ¿È­ µµ±¸´Â Strateos Cloud Lab Automation-as-a-Service Platform¿¡¼­ ¿Âµð¸Çµå ¹æ½ÄÀ¸·Î È®Àå °¡´ÉÇÑ Strateos Cloud Lab Automation-as-a-Service PlatformÀ» ±â¹ÝÀ¸·Î ¿î¿µµË´Ï´Ù. ÀÌ Ç÷§Æû¿¡´Â 23°³ÀÇ ¿öÅ©¼¿°ú ¼ö¹é °³ÀÇ Àåºñ¸¦ °®Ãá ·Îº¿ ÀÚµ¿È­°¡ ¿¬°áµÇ¾î ÀÖ¾î ¸®µå ÃÖÀûÈ­¸¦ ÅëÇÑ Á¶±â ¸®µå âÃâÀ» ÃËÁøÇÕ´Ï´Ù. »ç¿ëÀڴ Ŭ¶ó¿ìµå »ó¿¡¼­ È­ÇÕ¹°À» ¼³°èÇϰí, ¼¼Æ÷ ±â¹Ý, »ýÈ­ÇÐÀû, ±¸Á¶-Ȱ¼º »ó°ü°ü°è(SAR) Æò°¡ µî ´Ù¾çÇÑ ±â¹ýÀ» ÅëÇØ ÀÚµ¿À¸·Î Á¶¸³Çϰí Å×½ºÆ®ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, Äڷγª, ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´

Á¦34Àå ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Lab automation in drug discovery refers to the utilization of advanced technologies and robotics to streamline and optimize laboratory processes associated with new drug development and research. This approach aims to significantly improve the efficiency and success rate of drug discovery efforts by automating repetitive tasks and integrating sophisticated instruments and software. Automation in drug discovery laboratories can cover a wide range of activities, from high-throughput screening of compounds to data analysis and interpretation, allowing researchers to focus on more complex and creative aspects of their work.

The primary types of lab automation in drug discovery include automated liquid handlers, automated plate handlers, robotic arms, automated storage and retrieval systems, among others. Automated liquid handlers are machines specifically designed to dispense and handle liquids automatically. They are frequently employed in laboratories for precise and efficient liquid handling tasks such as pipetting and dilution. These automation solutions comprise various components, including instruments, software, and services, and find applications in high-throughput screening, compound management, sample preparation, and other processes. These technologies are utilized by various end-users, including biotechnology and pharmaceutical industries, research institutes, and others.

The lab automation in drug discovery research report is one of a series of new reports from The Business Research Company that provides lab automation in drug discovery market statistics, including the lab automation in drug discovery industry's global market size, regional shares, competitors with lab automation in drug discovery market share, detailed lab automation in drug discovery market segments, market trends and opportunities, and any further data you may need to thrive in the lab automation in drug discovery industry. This lab automation in drug discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The lab automation in drug discovery market size has grown strongly in recent years. It will grow from $6.47 billion in 2024 to $6.81 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to the increasing complexity of drug discovery, demand for efficiency and cost reduction, growing need for high-throughput screening, rising labor costs, and pressure to accelerate drug development timelines.

The lab automation in drug discovery market size is expected to see strong growth in the next few years. It will grow to $8.4 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to expanding drug pipelines of pharmaceutical companies, rise in personalized medicine and precision therapeutics, increasing focus on rare diseases and orphan drugs, demand for remote and decentralized clinical trials, the emergence of microfluidics and lab-on-a-chip technologies. Major trends in the forecast period include proliferation of modular and customizable automation solutions, adoption of cloud-based platforms for data management and collaboration, growth of automation in emerging markets, rise of virtual drug discovery companies leveraging automation and digital technologies, development of standardized protocols and interoperable systems.

The growing demand for precision medicine is anticipated to drive the growth of lab automation in the drug discovery market. Precision medicine, also known as personalized medicine, tailors medical treatment and prevention strategies based on individual variability in genes, environment, and lifestyle. Lab automation plays a pivotal role in accelerating research, enhancing experimental repeatability, and improving the efficiency of precision medicine and drug discovery procedures. This, in turn, leads to the development of more effective medicines and diagnostics tailored to individual patients. According to the Personalized Medicine Coalition (PMC) in October 2022, over 75,000 genetic testing products and 300 personalized medicines are expected to be available in the market, catering to individuals with various types of cancer, genetic rare diseases, and a range of chronic and infectious diseases. The rising demand for precision medicine is a key driver propelling the growth of lab automation in the drug discovery market.

Prominent companies operating in the lab automation in the drug discovery market are strategically focusing on developing advanced solutions, particularly rapid idea-to-data solutions, to gain a competitive edge. A rapid idea-to-data solution refers to a streamlined process or platform enabling individuals or organizations to quickly transform ideas or concepts into actionable insights or data-driven results. In April 2022, Strateos Inc., a US-based biotechnology company, introduced a rapid idea-to-data solution for small molecule discovery on its cloud lab automation-as-a-service platform. Specifically designed for small-molecule discovery in drug development, this lab automation tool operates on the on-demand and scalable Strateos Cloud Lab Automation-as-a-Service Platform. The platform includes linked robotic automation with 23 workcells and hundreds of instruments, facilitating early lead generation through lead optimization. Users can design compounds in the cloud and have them automatically assembled and tested using various methods such as cell-based, biochemical, and structured-activity relationship (SAR) assessments.

In March 2023, Brooks Automation, a US-based automation solution company, successfully acquired Aim Lab Automation Technologies Pty Ltd. for an undisclosed amount. This strategic acquisition aims to expand Brooks' presence in clinical diagnostics and drive technological advancements, significantly impacting lab automation in the drug discovery market. Aim Lab Automation Technologies Pty Ltd., based in Australia, provides robotic automation instrumentation and modules, along with automation solutions designed to enhance processes in drug discovery labs.

Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, AbCellera Biologics Inc., Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Arctoris, Inveox GmbH, Synthace, Synchron Lab Automation

North America was the largest region in the lab automation in drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lab automation in drug discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lab automation in drug discovery market consists of revenues earned by entities by providing services such as compound screening, assay development, high-throughput screening, data analysis, and optimization of drug candidates. The market value includes the value of related goods sold by the service provider or included within the service offering. The lab automation in drug discovery market also includes sales of robotics and automated workstations, screening systems, plate readers, and others. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lab Automation In Drug Discovery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lab automation in drug discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for lab automation in drug discovery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lab automation in drug discovery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Lab Automation In Drug Discovery Market Characteristics

3. Lab Automation In Drug Discovery Market Trends And Strategies

4. Lab Automation In Drug Discovery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Lab Automation In Drug Discovery Growth Analysis And Strategic Analysis Framework

6. Lab Automation In Drug Discovery Market Segmentation

7. Lab Automation In Drug Discovery Market Regional And Country Analysis

8. Asia-Pacific Lab Automation In Drug Discovery Market

9. China Lab Automation In Drug Discovery Market

10. India Lab Automation In Drug Discovery Market

11. Japan Lab Automation In Drug Discovery Market

12. Australia Lab Automation In Drug Discovery Market

13. Indonesia Lab Automation In Drug Discovery Market

14. South Korea Lab Automation In Drug Discovery Market

15. Western Europe Lab Automation In Drug Discovery Market

16. UK Lab Automation In Drug Discovery Market

17. Germany Lab Automation In Drug Discovery Market

18. France Lab Automation In Drug Discovery Market

19. Italy Lab Automation In Drug Discovery Market

20. Spain Lab Automation In Drug Discovery Market

21. Eastern Europe Lab Automation In Drug Discovery Market

22. Russia Lab Automation In Drug Discovery Market

23. North America Lab Automation In Drug Discovery Market

24. USA Lab Automation In Drug Discovery Market

25. Canada Lab Automation In Drug Discovery Market

26. South America Lab Automation In Drug Discovery Market

27. Brazil Lab Automation In Drug Discovery Market

28. Middle East Lab Automation In Drug Discovery Market

29. Africa Lab Automation In Drug Discovery Market

30. Lab Automation In Drug Discovery Market Competitive Landscape And Company Profiles

31. Lab Automation In Drug Discovery Market Other Major And Innovative Companies

32. Global Lab Automation In Drug Discovery Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lab Automation In Drug Discovery Market

34. Recent Developments In The Lab Automation In Drug Discovery Market

35. Lab Automation In Drug Discovery Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â